back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-08 10:05 Tx date 2024-11-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
9,829 | ||
| Filed 2025-03-08 10:04 Tx date 2023-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+33,373 vol |
33,373 | |
| Filed 2025-03-08 09:47 Tx date 2025-03-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-137,334.01
-16,687 vol $8.23 each |
72,011 | |
| Filed 2025-03-08 09:43 Tx date 2025-03-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,382 vol |
18,890 | |
| Filed 2024-11-13 11:09 Tx date 2023-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+43,203 vol |
||
| Filed 2024-11-13 10:56 Tx date 2023-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+50,060 vol |
||
| Filed 2024-11-13 10:38 Tx date 2024-11-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-05 15:17 Tx date 2025-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+62,583 vol |
62,583 | |
| Filed 2025-03-05 15:15 Tx date 2024-11-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-05 15:15 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-181,976
-22,747 vol $8.00 each |
88,698 | |
| Filed 2025-03-05 15:13 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+10,508 vol |
10,508 | |
| Filed 2024-11-13 11:09 Tx date 2023-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+43,203 vol |
43,203 | |
| Filed 2024-11-13 10:58 Tx date 2024-01-30 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+68,242 vol |
118,302 | |
| Filed 2024-11-13 10:56 Tx date 2023-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+50,060 vol |
50,060 | |
| Filed 2024-11-13 10:56 Tx date 2023-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+50,060 vol |
||
| Filed 2024-11-13 10:52 Tx date 2024-11-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-11-13 10:51 Tx date 2023-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$737,090
+81,990 vol $8.99 each |
81,990 | |
| Filed 2024-11-13 10:44 Tx date 2024-11-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-11-13 10:38 Tx date 2024-11-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|